All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BIODESIX INC Last Reported: 12/31/2020 Stock Symbol: BDSX

Business Address

2970 WILDERNESS PLACE
SUITE 100
BOULDER, CO US 80301

Mailing Address

2970 WILDERNESS PLACE
SUITE 100
BOULDER, CO US 80301
Phone Number: 303-417-0500 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $6,348,000.00 -- -- $5,286,000.00 -- -- -- --
Accounts Receivable Net Current $5,396,000.00 -- -- $5,292,000.00 -- -- -- --
Inventory -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- --
Total Current Assets $18,149,000.00 -- -- $12,700,000.00 -- -- -- --
Property Plant and Equipement $3,005,000.00 -- -- $2,120,000.00 -- -- -- --
Intangible Assets Net $13,667,000.00 -- -- $15,092,000.00 -- -- -- --
Goodwill $11,631,000.00 -- -- $11,631,000.00 -- -- -- --
Other Assets -- -- -- -- -- -- -- --
Total Assets $46,547,000.00 -- -- $41,633,000.00 -- -- -- --
Accounts Payable $3,485,000.00 -- -- $1,717,000.00 -- -- -- --
Accrued Liabilities $6,953,000.00 -- -- $4,180,000.00 -- -- -- --
Total Current Liabilities $107,764,000.00 -- -- $76,213,000.00 -- -- -- --
Long Term Debt $24,787,000.00 -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- --
Accumulated Deficit $-257,681,000.00 -- -- $-230,864,000.00 -- -- -- --
Total Stockholders' Equity $-255,176,000.00 $-246,445,000.00 $-238,234,000.00 $-228,539,000.00 $-222,059,000.00 $-212,519,000.00 $-205,713,000.00 $-198,030,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- --
Total Liabilities and Equity $46,547,000.00 -- -- $41,633,000.00 -- -- -- --

Statement of Operations

Date 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Total Revenues $18,528,000.00 -- -- -- $16,281,000.00 -- -- --
Cost of Revenues -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- --
Research and Development $2,706,000.00 -- -- -- $2,359,000.00 -- -- --
Selling, General, and Administrative $7,879,000.00 -- -- -- $24,080,000.00 -- -- --
Total Operating Expenses $38,809,000.00 -- -- -- $12,970,000.00 -- -- --
Loss from Operations $-6,240,000.00 -- -- -- $-9,028,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- --
Common Stock Shares Authorized 220,000,000 -- -- 190,000,000 -- -- -- --
Common Stock Shares Outstanding 289,508 -- -- 254,918 -- -- -- --
Common Stock Value $2,000.00 -- -- $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- --
Copyright 2021 PursePoor.com